Etopride is a new generation of gastrointestinal motility drug with good safety effect, which is safer than the previous Mosapride. Etopride is also recommended to be used on an empty stomach 30 minutes before meals, and the course of treatment is 2-4 weeks, and the patient will have some improvement in the initial use, which is mainly used clinically to relieve reflux, nausea, constipation, and for symptoms of poor gastrointestinal motility function, Etopride has obvious relief effect. Etopride is not metabolized by hepatic P450 metabolizing enzymes, so it has fewer side effects with other drugs and is clinically safe to take for 2-4 weeks, unless the patient has intestinal obstruction and other adverse clinical conditions. Etopride is safe to take, especially for older patients with cardiovascular and multiple drug use at the same time.